ArticleScientific reports2025
Synthesis of 2'-fucosyllactose using multi-enzyme cascade with cofactor regeneration.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
2'-Fucosyllactose (2'-FL) is a major human milk oligosaccharide with nutritional and medicinal benefits, widely used in infant formula and nutraceuticals. Now most studies focus on the synthesis of 2'-FL in vivo starting from glucose and glycerol. Here, we designed the first in vitro multi-enzyme cascade system for the de novo synthesis of 2'-FL using mannose and lactose as substrates. Central to this pathway is an engineered polyphosphate-dependent glucomannokinase (PPGMK), which enables efficient phosphorylation of mannose to G6P and thereby establishes mannose as an effective entry point for the de novo synthetic route. To enhance the production of 2'-FL, the cascade system was optimized, and apart from α-1,2-fucosyltransferase, GDP-D-mannose-4,6-dehydratase (gmd) was determined as a crucial rate-limiting enzyme for the de novo synthesis of 2'-FL. Additionally, an efficient GTP regeneration system was achieved, which converted GDP to GTP using polyphosphate kinase 2, resulting in a 2.94-fold improvement in 2'-FL production. Finally, under optimized conditions incorporating the cofactor regeneration system, 13.18 mM 2'-FL was synthesized through a one-pot enzymatic reaction using 20 mM mannose and lactose as substrates. The engineered system demonstrated exceptional cofactor efficiency, requiring only 2 mM each of the essential cofactor NADPH and GTP representing a 6.6-fold reduction in cofactor consumption. Overall, this study establishes a novel de novo enzymatic route for 2'-FL and provides new insights for both pathway construction and enzyme engineering in oligosaccharide production.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.